| |
| |
|
| Insider
Information: |
Anido Armando |
| Relationship: |
|
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
26,472 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38,500 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
26,472 |
|
|
| Total
Value |
$38,500 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
3
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 9.0%
|
40.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medimmune Inc |
MEDI |
EVP, Sales and Mktg |
2006-02-03 |
1,472 |
2005-11-08 |
0 |
Premium* |
|
|
Adolor Corp |
ADLR |
Director |
2011-12-07 |
0 |
2007-05-17 |
0 |
Premium* |
|
|
Zynerba Pharmaceuticals, Inc. |
ZYNE |
|
2023-10-10 |
0 |
2023-10-10 |
0 |
Premium* |
|
|
Scynexis Inc |
SCYX |
|
2023-06-15 |
25,000 |
2020-12-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-10-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,176,722) |
0 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
240,000 |
610,000 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-10-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(39,892) |
0 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-09-13 |
4 |
S |
$1.33 |
$23,637 |
D/D |
(17,830) |
936,722 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
64,747 |
954,552 |
0 |
- |
|
| SCYX |
Scynexis Inc |
|
• • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
25,000 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-02-08 |
4 |
D |
$0.60 |
$7,484 |
D/D |
(12,547) |
889,805 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
45,406 |
902,352 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-02-01 |
4 |
D |
$0.60 |
$6,979 |
D/D |
(11,726) |
856,946 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
42,437 |
868,672 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
826,235 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2023-01-23 |
4 |
S |
$0.60 |
$21,194 |
D/D |
(35,453) |
576,235 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2022-07-19 |
4 |
S |
$1.10 |
$13,089 |
D/D |
(11,899) |
611,688 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2022-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
43,164 |
623,587 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
15,000 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
580,423 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2021-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
107,911 |
460,423 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2020-12-21 |
4 |
B |
$6.25 |
$31,250 |
D/D |
5,000 |
5,000 |
2.39 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2018-08-06 |
4 |
B |
$5.96 |
$89,423 |
D/D |
15,000 |
352,512 |
2.81 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2017-05-15 |
4 |
B |
$19.57 |
$29,355 |
D/D |
1,500 |
337,512 |
2.81 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2017-05-12 |
4 |
B |
$19.76 |
$69,160 |
D/D |
3,500 |
336,012 |
2.81 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2015-08-10 |
4 |
A |
$0.00 |
$0 |
I/I |
39,892 |
13,297 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chairman & Chief Exec. Officer |
• • – |
2015-08-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
332,512 |
|
- |
|
| ADLR |
Adolor Corp |
Director |
– • – |
2011-12-07 |
4 |
OE |
$1.39 |
$290,400 |
D/D |
150,000 |
160,450 |
0 |
- |
|
| ADLR |
Adolor Corp |
Director |
– • – |
2011-12-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(160,450) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
